Kura Oncology, Inc.
KURA institutional ownership changes in Q2 2026: 71 institutions opened or added positions, 50 trimmed or exited. KURA (Kura Oncology, Inc.) is held by 124 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($115.3M), State Street Corp. ($58.5M), Vanguard Capital Management LLC ($43M). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Sep 29, 2026 · Activists Oct 27, 2026 · Congress none
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 10.5M(+9.0%) | $115.3M | 0.0% | -36.08% | 33 | |
Increased | 5.3M(+18.1%) | $58.5M | 0.0% | -29.04% | 35 | |
Increased | 3.9M(+3.5%) | $43M | 0.0% | +20.13% | 30 | |
Increased | 3.1M(+47.2%) | $34.3M | 0.0% | +2.58% | 40 | |
Increased | 2.3M(+58.0%) | $24.8M | 0.0% | -10.87% | 41 | |
Increased | 2.2M(+9.6%) | $24.5M | 0.0% | -35.71% | 31 | |
Increased | 1.7M(+5.1%) | $18.3M | 0.0% | +7.70% | 30 | |
New | 1.4M | $15.5M | 0.0% | -9.94% | 39 | |
Increased | 1.3M(+8.1%) | $14.6M | 0.0% | +18.44% | 30 | |
Decreased | 1.2M(-28.5%) | $12.8M | 0.0% | +21.96% | 0 | |
Decreased | 1.2M(-18.0%) | $12.8M | 0.0% | -24.02% | 0 | |
Decreased | 1.2M(-5.6%) | $12.7M | 0.0% | +0.60% | 0 | |
Decreased | 1.2M(-0.3%) | $12.7M | 0.0% | -23.20% | 0 | |
Increased | 996,114(+24.4%) | $10.9M | 0.0% | +3.71% | 34 | |
Decreased | 964,636(-7.3%) | $10.6M | 0.0% | -0.67% | 0 | |
Increased | 948,974(+57.6%) | $10.4M | 0.0% | +5.82% | 40 | |
Increased | 831,160(+9.9%) | $9.1M | 0.0% | -32.44% | 30 | |
Decreased | 711,332(-54.5%) | $7.8M | 0.0% | -4.66% | 0 | |
Decreased | 676,400(-2.1%) | $7.4M | 0.0% | -37.86% | 0 | |
Increased | 629,560(+13.4%) | $6.9M | 0.0% | +16.70% | 31 |
Showing 1-20 of 133
| Insider | Trade | Traded |
|---|---|---|
| FORD KATHLEEN | Sell $39K | |
| Powl Brian T. | Sell $166K | |
| Leoni Mollie | Sell $310K | |
| Powl Brian T. | Sell $84K | |
| DOYLE THOMAS JAMES | Sell $48K | |
| Powl Brian T. | Sell $95K | |
| FORD KATHLEEN | Sell $72K | |
| Bair Teresa Brophy | Sell $89K | |
| Leoni Mollie | Sell $131K | |
| Burrows Francis | Exercise 30K sh |
| Filer | Stake | Filed |
|---|---|---|
| BlackRock, Inc. | 8.9% | |
| Montanova Capital, LLC | 9.7% | |
| Armistice Capital, LLC | 4.2% | |
| Vanguard Capital Management | 5.0% | |
| The Vanguard Group | 0.0% | |
| STATE STREET CORPORATION | 5.7% | |
| BIOTECHNOLOGY VALUE FUND L P | 5.1% | |
| EcoR1 Capital, LLC | 4.8% | |
| RA Capital Management, L.P. | 4.9% | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.4% |
KURAKura Oncology, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about KURA
Who owns KURA?
124 institutional investors held KURA on June 30, 2026, led by BlackRock, Inc. ($115.3M), State Street Corp. ($58.5M) and Vanguard Capital Management LLC ($43M).
How many hedge funds hold KURA?
124 institutional investors reported KURA in their 13F filings for the quarter ended June 30, 2026, $575.9M in all. 6 of them are rated Elite.
Are institutions buying or selling KURA?
Buying, on balance. In Q2 2026, 71 institutions opened or added to positions in KURA and 50 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer